MedTrace Logo

The Feasibility, Safety and Tolerability of VR-based Audiovisual Stimulation

NCT06234930 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2025-09-02

No results posted yet for this study

Summary

This is a single-blind, sham-controlled, clinical trial that aims to evaluate the safety, tolerability, and feasibility of delivering audiovisual stimulation via a Virtual Reality (VR) headset to people cognitively impaired due to Alzheimer's and cognitively unimpaired people.

Conditions

Interventions

DEVICE

Audiovisual stimulation VR system

Delivery of synchronized auditory and visual stimuli at varying frequencies via a VR headset.

Sponsors & Collaborators

  • Clarity Health Technologies, Inc

    lead INDUSTRY

Principal Investigators

  • Carolina Reis, PhD · Clarity Health Technologies

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-11
Primary Completion
2025-03-14
Completion
2025-03-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06234930 on ClinicalTrials.gov